Latest News in the pharma Industry

Top Stories

New fund to benefit pancreatic cancer research

New fund to benefit pancreatic cancer research

28 Jan 2013

US foundation commits £25 million to fighting pancreatic cancer.

Read more 
Avoca Group announces key initiatives for outsourcing consortium

Avoca Group announces key initiatives for outsourcing consortium

28 Jan 2013

Avoca's outsourcing group has set out its key goals for 2013.

Read more 
Skin substitute trials 'a success'

Skin substitute trials 'a success'

21 Jan 2013

Patients will no longer have to undergo painful autografting for second-degree burns.

Read more 
BioChemics patents wound healing treatment

BioChemics patents wound healing treatment

21 Jan 2013

BioChemics ventures into wound treating market.

Read more 
Top pharmacists gather for conference

Top pharmacists gather for conference

21 Jan 2013

Independent pharmaceutical companies to discuss the changing industry.

Read more 
Anacor director receives science award

Anacor director receives science award

21 Jan 2013

Scientific medal goes to Dr Lucy Shapiro of Anacor Pharmaceuticals.

Read more 
Spectrum Pharmaceuticals outlines five-year vision

Spectrum Pharmaceuticals outlines five-year vision

11 Jan 2013

Spectrum announces new arrival plus its plan for the next five years.

Read more 
Outsourcing market to value $41bn

Outsourcing market to value $41bn

11 Jan 2013

Device outsourcing set to rise exponentially between now and 2018.

Read more 
Pharmaceutical companies increase outsourcing

Pharmaceutical companies increase outsourcing

10 Jan 2013

Number of pharmaceutical companies using outsourcing increases.

Read more 
Brain tumour investment 'lagging'

Brain tumour investment 'lagging'

7 Jan 2013

Funding for research and treatment of brain tumours is 'lagging behind' other cancers, says a charity.

Read more 
South Korea set for global biosimilars leadership

South Korea set for global biosimilars leadership

7 Jan 2013

A Frost & Sullivan report has predicted significant growth in the South Korean biosimilars market between now and 2020.

Read more 
Pfizer Licenses Quinazoline Drug Program

Pfizer Licenses Quinazoline Drug Program

5 Jan 2013

Repligen Corp. has entered into an exclusive worldwide licensing agreement with Pfizer to advance its spinal muscular atrophy (SMA) program, originally in-licensed from Families of SMA (FSMA).

Read more